One Global Service Provider Ltd
₹ 298
1.99%
21 Feb
- close price
About
Incorporated in 1992, One Global Service
Provider Ltd is in the business of healthcare services[1]
Key Points
- Market Cap ₹ 211 Cr.
- Current Price ₹ 298
- High / Low ₹ 359 / 70.9
- Stock P/E 18.4
- Book Value ₹ 25.9
- Dividend Yield 0.34 %
- ROCE 84.8 %
- ROE 65.6 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 92.4% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 41.8%
- Company's working capital requirements have reduced from 89.3 days to 57.1 days
Cons
- Stock is trading at 11.5 times its book value
- Promoter holding is low: 29.5%
- Company has high debtors of 152 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 4 | 6 | 18 | 63 | 91 | |
0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 5 | 16 | 53 | 75 | |
Operating Profit | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 2 | 10 | 16 |
OPM % | 73% | 14% | 68% | 23% | 9% | 15% | 17% | ||||||
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | 1 | -0 | -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 1 | 10 | 15 |
Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -3% | -1% | 25% | |
1 | -0 | -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 1 | 7 | 11 | |
EPS in Rs | 1.20 | -0.35 | -0.14 | -0.11 | -0.13 | 0.27 | 0.38 | -0.42 | 3.28 | 1.48 | 1.94 | 10.01 | 16.17 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 102% |
3 Years: | 158% |
TTM: | 106% |
Compounded Profit Growth | |
---|---|
10 Years: | 41% |
5 Years: | 92% |
3 Years: | 45% |
TTM: | 222% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 132% |
3 Years: | 110% |
1 Year: | 259% |
Return on Equity | |
---|---|
10 Years: | 28% |
5 Years: | 40% |
3 Years: | 42% |
Last Year: | 66% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
Reserves | -4 | -4 | -5 | -5 | -5 | -5 | -4 | -5 | -2 | -1 | 0 | 7 | 11 |
0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 2 | 5 | 17 | 20 | |
Total Liabilities | 3 | 3 | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 39 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |
CWIP | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 3 | 5 | 9 | 28 | 36 | |
Total Assets | 3 | 3 | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 39 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | -0 | -0 | -0 | -0 | -0 | 0 | -0 | 1 | 1 | 0 | 1 | |
-2 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -0 | -0 | |
0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | |
Net Cash Flow | 0 | -0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 1 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 365 | 149 | 0 | 242 | 164 | 152 | ||||||
Inventory Days | 0 | 0 | 0 | 0 | 0 | |||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 365 | 149 | 0 | 242 | 164 | 152 | ||||||
Working Capital Days | 421 | 37 | 149 | 135 | 76 | 57 | ||||||
ROCE % | -4% | -9% | -4% | -3% | -3% | 6% | 9% | -11% | 60% | 18% | 20% | 85% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Feb - Newspaper intimation for the Quarter ended 31 December 2024
-
Integrated Filing (Financial)
14 Feb - Integrated filing of financial results for Q3 2024.
-
Result For The Quarter Ended 31 December 2024
11 Feb - Board approved standalone unaudited financial results for Q3 2024.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, 11Th February, 2025
11 Feb - Board approved standalone unaudited financial results.
-
Board Meeting Intimation for Notice Of The Board Meeting
4 Feb - Board meeting to approve Q4 financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
a) OGSPL provides services in Life Sciences and Healthcare Solutions across the globe.
b) Company has expertise in mass
screening, diagnostics and healthcare sciences used by hospitals, healthcare professionals and government bodies.
d) Company has started providing consultancy and development in software
and other IT solutions
e) It provides a single online platform
with healthcare products ranging from
medical devices to medical consumables.